Search Results - Nick Thatcher

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer

    ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer by Richard Booton, Tim Ward, Linda Ashcroft, Julie Morris, Jim Heighway, Nick Thatcher

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer

    Randomized Phase III Trial of Dose-Dense Chemotherapy Supported by Whole-Blood Hematopoietic Progenitors in Better-Prognosis Small-Cell Lung Cancer by Paul Lorigan, Penella J. Woll, Mary O’Brien, Linda Ashcroft, M Sampson, Nick Thatcher

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Epidermal growth factor receptor immunohistochemistry

    Epidermal growth factor receptor immunohistochemistry by Fred R. Hirsch, Rafał Dziadziuszko, Nick Thatcher, Helen Mann, Claire Watkins, Dinah V. Parums, Georgina Speake, Brian R. Holloway, Paul A. Bunn, Wilbur A. Franklin

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study

    Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study by Alex Y. Chang, Purvish M. Parikh, Sumitra Thongprasert, Eng Huat Tan, Reury-Perng Perng, Domingo Ganzon, James Chih‐Hsin Yang, Chao‐Jung Tsao, Claire Watkins, N. Botwood, Nick Thatcher

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Second-Line Treatment of Advanced Non-small Cell Lung Cancer

    Second-Line Treatment of Advanced Non-small Cell Lung Cancer by Cesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, Nasser H. Hanna, John V. Heymach, Francesco Perrone, Rafael Rosell, Frances A. Shepherd, Nick Thatcher, Johan Vansteenkiste, Luigi De Petris, Massimo Di Maïo, Filippo de Marinis

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012

    Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012 by Fred R. Hirsch, Pasi A. Jänne, Wilfried Eberhardt, Federico Cappuzzo, Nick Thatcher, Robert Pirker, Hak Choy, Edward S. Kim, Luis Paz‐Ares, David R. Gandara, Yi‐Long Wu, Myung‐Ju Ahn, Tetsuya Mitsudomi, Frances A. Shepherd, Tony Mok

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer

    Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer by Mark A. Socinski, Egbert F. Smit, Paul Lorigan, Kartik Konduri, Martin Reck, Aleksandra Szczęsna, Johnetta Blakely, Piotr Serwatowski, Nina Karaseva, Tudor‐Eliade Ciuleanu, Jacek Jassem, Mircea Dediu, Shengyan Hong, Carla Visseren‐Grul, Axel-Rainer Hanauske, Coleman K. Obasaju, Susan C. Guba, Nick Thatcher

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

    Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an o... by Nick Thatcher, Fred R. Hirsch, Alexander Luft, Aleksandra Szczęsna, Tudor‐Eliade Ciuleanu, Mircea Dediu, Rodryg Ramlau, Rinat Galiulin, Beatrix Bálint, György Losonczy, Andrzej Każarnowicz, Keunchil Park, Christian Schumann, Martin Reck, H. Depenbrock, Shivani Nanda, Anamarija Kruljac‐Letunic, Raffael Kurek, Luis Paz‐Ares, Mark A. Socinski

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer

    Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer by Mark A. Socinski, Coleman K. Obasaju, David R. Gandara, Fred R. Hirsch, Philip Bonomi, Paul A. Bunn, Edward S. Kim, Corey J. Langer, Ronald B. Natale, Silvia Novello, Luis Paz‐Ares, M. Pérol, Martin Reck, Suresh S. Ramalingam, Craig H. Reynolds, David R. Spigel, Heather A. Wakelee, Nick Thatcher

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment

    Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment by Corey J. Langer, Coleman K. Obasaju, Paul A. Bunn, Philip Bonomi, David R. Gandara, Fred R. Hirsch, Edward S. Kim, Ronald B. Natale, Silvia Novello, Luis Paz‐Ares, M. Pérol, Martin Reck, Suresh S. Ramalingam, Craig H. Reynolds, Mark A. Socinski, David R. Spigel, Heather A. Wakelee, Carlos Mayo, Nick Thatcher

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer

    Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer by Fred R. Hirsch, Marileila Varella‐Garcia, Paul A. Bunn, Wilbur A. Franklin, Rafał Dziadziuszko, Nick Thatcher, Alex Y. Chang, Purvish M. Parikh, José Rodrigues Pereira, Tudor‐Eliade Ciuleanu, Joachim von Pawel, Claire Watkins, Angela V. Flannery, Gillian Ellison, Emma Donald, Lucy Knight, Dinah V. Parums, Nicholas Botwood, Brian R. Holloway

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

    Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial by Charles Butts, Mark A. Socinski, Paul Mitchell, Nick Thatcher, Libor Havel, Maciej Krzakowski, Sergiusz Nawrocki, Tudor‐Eliade Ciuleanu, Lionel Bosquée, José Trigo, Alexander I. Spira, Lise Tremblay, Jan Nyman, Rodryg Ramlau, Gun Wickart-Johansson, Peter Ellis, Oleg Gladkov, José Rodrigues Pereira, Wilfried Eberhardt, Christoph Helwig, Andreas Schröder, Frances A. Shepherd

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Clinicopathologic Features of Advanced Squamous NSCLC

    Clinicopathologic Features of Advanced Squamous NSCLC by Mark A. Socinski, Coleman K. Obasaju, David Gandara, Fred R. Hirsch, Philip Bonomi, Paul A. Bunn, Edward S. Kim, Corey J. Langer, Ronald B. Natale, Silvia Novello, Luis Paz‐Ares, M. Pérol, Martin Reck, Suresh S. Ramalingam, Craig H. Reynolds, David R. Spigel, Thomas E. Stinchcombe, Heather A. Wakelee, Carlos Mayo, Nick Thatcher

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

    Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled p... by Luis Paz‐Ares, J. Mezger, Tudor‐Eliade Ciuleanu, Jürgen R. Fischer, Joachim von Pawel, Mariano Provencio, Andrzej Każarnowicz, György Losonczy, Gilberto de Castro, Aleksandra Szczęsna, Lucio Crinò, Martin Reck, Rodryg Ramlau, Ernst Ulsperger, Christian Schumann, José Elias Miziara, Álvaro Edson Ramos Lessa, Mircea Dediu, Beatrix Bálint, H. Depenbrock, Victoria Soldatenkova, Raffael Kurek, Fred R. Hirsch, Nick Thatcher, Mark A. Socinski

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: